Get the Stockscreener App
71.84
4.33%
2.9912
Synchrony Financial stock is traded at $71.84, with a volume of 1.79M.
It is up +4.33% in the last 24 hours and up +7.74% over the past month.
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
See More
Previous Close:
$68.85
Open:
$72.18
24h Volume:
1.79M
Relative Volume:
0.39
Market Cap:
$24.97B
Revenue:
$19.12B
Net Income/Loss:
$3.55B
P/E Ratio:
7.7378
EPS:
9.2844
Net Cash Flow:
$9.85B
1W Performance:
+5.14%
1M Performance:
+7.74%
6M Performance:
+1.21%
1Y Performance:
+63.88%
1-Day Range:
$71.35
$72.81
1-Week Range:
$66.00
$72.81
52-Week Range:
$42.09
$88.77
Synchrony Financial Stock (SYF) Company Profile
Name
Synchrony Financial
Sector
Industry
Phone
203 585-2400
Address
777 LONG RIDGE ROAD, STAMFORD
Compare SYF vs V, MA, AXP, COF, PYPL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYF
Synchrony Financial
|
71.83 | 23.93B | 19.12B | 3.55B | 9.85B | 9.2844 |
V
Visa Inc
|
309.84 | 581.87B | 41.39B | 20.59B | 22.93B | 10.55 |
MA
Mastercard Incorporated
|
511.49 | 444.37B | 32.84B | 14.97B | 16.19B | 16.52 |
AXP
American Express Co
|
316.33 | 210.56B | 80.49B | 10.76B | 16.08B | 15.38 |
COF
Capital One Financial Corp
|
191.91 | 112.66B | 69.28B | 2.01B | 26.14B | 2.9491 |
PYPL
Paypal Holdings Inc
|
46.15 | 41.31B | 33.34B | 5.23B | 5.56B | 5.4094 |
Synchrony Financial Stock (SYF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-28-26 | Upgrade | Compass Point | Neutral → Buy |
| Dec-08-25 | Resumed | Wolfe Research | Outperform |
| Dec-05-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-10-25 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Jul-14-25 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-07-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-28-25 | Downgrade | Compass Point | Buy → Neutral |
| Jan-06-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-19-24 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Dec-09-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-03-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-16-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-16-24 | Initiated | Compass Point | Buy |
| Jun-28-24 | Initiated | Robert W. Baird | Outperform |
| Jun-07-24 | Initiated | BTIG Research | Buy |
| May-02-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Apr-04-24 | Upgrade | Wolfe Research | Underperform → Outperform |
| Feb-08-24 | Resumed | Morgan Stanley | Underweight |
| Jan-10-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-10-24 | Initiated | Deutsche Bank | Buy |
| Nov-15-23 | Initiated | Barclays | Equal Weight |
| Nov-01-23 | Initiated | TD Cowen | Outperform |
| Oct-13-23 | Initiated | HSBC Securities | Hold |
| Sep-05-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-14-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-17-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Mar-17-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-06-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-13-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-01-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-21-22 | Initiated | UBS | Neutral |
| Jul-13-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-12-22 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-28-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-17-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-31-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-31-22 | Reiterated | Piper Sandler | Neutral |
| Jan-31-22 | Reiterated | Seaport Research Partners | Buy |
| Jan-31-22 | Reiterated | Stephens | Equal-Weight |
| Jan-03-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-29-21 | Initiated | Piper Sandler | Neutral |
| Oct-29-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-20-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-30-21 | Initiated | Seaport Global Securities | Buy |
| Jul-09-21 | Resumed | Citigroup | Neutral |
| Apr-14-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-09-21 | Initiated | Evercore ISI | Outperform |
| Jan-19-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-10-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-30-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-20 | Initiated | Deutsche Bank | Buy |
| Jul-31-20 | Initiated | Wolfe Research | Outperform |
| Jul-15-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-27-20 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-05-19 | Downgrade | Nomura | Buy → Neutral |
| Dec-02-19 | Resumed | BofA/Merrill | Buy |
| May-03-19 | Resumed | RBC Capital Mkts | Outperform |
| Feb-14-19 | Upgrade | Goldman | Neutral → Buy |
| Jan-30-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-24-19 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-03-19 | Upgrade | Stephens | Underweight → Equal-Weight |
| Sep-26-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-17-18 | Initiated | RBC Capital Mkts | Outperform |
| Apr-05-18 | Initiated | Citigroup | Neutral |
| Mar-14-18 | Initiated | Buckingham Research | Buy |
| Jan-09-18 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Dec-18-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-11-17 | Resumed | Wells Fargo | Market Perform |
View All
Synchrony Financial Stock (SYF) Latest News
CT law mandated new kind of education for high schoolers. Here’s how it’s going - Hartford Courant
PAID POST: Personal Finance is a High School Requirement, Why Synchrony is Supporting Teachers - CT Mirror
Walmart Website Now Accepts CareCredit for Health and Wellness Products - PYMNTS.com
A Look At Synchrony Financial’s Valuation As CareCredit Expands On Walmartcom And New Initiatives Roll Out - Yahoo Finance
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery - Zacks Investment Research
Synchrony tops Fortune Best Companies list - Powersports Business
UBS Maintains Synchrony Financial(SYF.US) With Hold Rating, Cuts Target Price to $77 - 富途牛牛
UBS Adjusts Synchrony Financial Price Target to $77 From $82, Maintains Neutral Rating - marketscreener.com
Walmart accepting Synchrony CareCredit payments online - Chain Store Age
Synchrony's CareCredit Credit Card Now Accepted on Walmart.com - marketscreener.com
12 million CareCredit users can now buy wellness gear on Walmart.com - Stock Titan
Autonomous Research Adjusts PT on Synchrony Financial to $73 From $81, Maintains Neutral Rating - Moomoo
Goldman Sachs Adjusts Price Target on Synchrony Financial to $90 From $93, Maintains Buy Rating - marketscreener.com
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System - FinancialContent
Synchrony Financial stock outperforms competitors on strong trading day - MarketWatch
Synchrony Financial: Sell-Off Presents Great Entry Point For Shares (Upgrade) (NYSE:SYF) - Seeking Alpha
A Look At Synchrony Financial (SYF) Valuation After New Figo Pet Insurance Partnership - simplywall.st
Barclays Lowers Price Target for SYF, Maintains Overweight Ratin - GuruFocus
Synchrony Financial (NYSE:SYF) Price Target Cut to $82.00 by Analysts at Barclays - MarketBeat
Synchrony Financial earnings preview: What to expect - MSN
Stereotaxis Shares Rise on FDA Clearance for Synchrony - marketscreener.com
Seaport Global Adjusts Price Target on Synchrony Financial to $84 From $95, Maintains Buy Rating - marketscreener.com
Synchrony Financial Earnings Preview: Analysts Forecast Double-Digit Profit Growth - nationaltoday.com
Synchrony Financial Earnings Preview: What to Expect - Barchart
Stereotaxis Announces FDA Clearance and Launch of Synchrony System - GlobeNewswire
Synchrony Puts Teachers First This Financial Literacy Month with $2 Million Commitment to Bring Training, Tools, and Financial Literacy Labs to U.S. High Schools - StreetInsider
Synchrony Financial (SYF) Stock forecasts - Yahoo Finance UK
Barclays Adjusts Price Target on Synchrony Financial to $82 From $93, Maintains Overweight Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Synchrony Financial to $80 From $88, Maintains Outperform Rating - marketscreener.com
Synchrony price target lowered to $82 from $93 at Barclays - TipRanks
Aberdeen Group plc Has $25.01 Million Holdings in Synchrony Financial $SYF - MarketBeat
Best CD Rates Of April 2026: Up To 4.35% APY - Forbes
10 Best High-Yield Savings Accounts Of April 2026: Up to 5.00% APY - Forbes
Synchrony's 40% EPS Beat Could Trigger Re-Rating—But Credit Actions Remain a Growth Red Flag - Bitget
Sovran Advisors LLC Has $4.26 Million Stake in Synchrony Financial $SYF - MarketBeat
Jim Cramer Says He Prefers Capital One Over Synchrony Financial - MSN
Synchrony Financial R (SFE.F) Q1 FY2025 earnings call transcript - Yahoo Finance
13 Best CD Rates of April 2026: Earn Up To 4.10% APY - CNBC
Synchrony Financial (NYSE:SYF) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Synchrony Financial (SYF) director receives 883 restricted stock units grant - Stock Titan
Synchrony Financial (NYSE: SYF) director granted 883 restricted stock units - Stock Titan
Synchrony Financial (SYF) director receives 1,343 restricted stock units - Stock Titan
Synchrony Financial (SYF) director granted 883 restricted stock units vesting in 2027 - Stock Titan
Synchrony Financial (NYSE: SYF) director awarded 883 restricted stock units - Stock Titan
Director Ellen Zane granted 883 RSUs at Synchrony (NYSE: SYF) - Stock Titan
Synchrony Financial (SYF) director granted 883 restricted stock units - Stock Titan
Director at Synchrony (NYSE: SYF) receives 883 RSUs vesting 2027 - Stock Titan
Synchrony Financial (SYF) director receives 883 RSUs - Stock Titan
Synchrony Financial (SYF) director granted 883 restricted stock units vesting 2027 - Stock Titan
Director Parker receives 883 RSUs in Synchrony Financial (NYSE: SYF) - Stock Titan
Stock Traders Buy High Volume of Synchrony Financial Put Options (NYSE:SYF) - MarketBeat
Synchrony Financial Stock (SYF) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):